Home » Topics » BioWorld Science

BioWorld Science
RSS

HLA fine mapping identifies INPP5A as a risk gene for tuberculosis

Oct. 21, 2021

Tango Therapeutics' MTAPnull PRMT5 inhibitor TNG-908 active in multiple xenograft tumor models

Oct. 21, 2021

NPAS3 identified as a risk gene for autism spectrum disorder

Oct. 21, 2021

Mitochondrial augmentation: a promising disease-modifying strategy for mitochondrial DNA disorders

Oct. 21, 2021

Alu RNA induces retinal pigment epithelium degeneration in geographic atrophy via the inflammasome

Oct. 21, 2021

Medshine Discovery describes new compounds for cancer

Oct. 21, 2021

Dongguan Hec New Drug Research and Development synthesizes new HBV antivirals

Oct. 21, 2021

Angiex presents new TM4SF1-targeting PROTACs

Oct. 21, 2021

Whole exome sequencing analysis identifies novel genes associated with osteoarthritis

Oct. 21, 2021

Chinese researchers disclose new ROS inhibitors

Oct. 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...